New acne gel shows promise in Head-to-Head trial
NCT ID NCT04892706
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 30 times
Summary
This study tested a new gel called IDP-126 against a standard acne treatment (Epiduo® Forte) and a placebo gel. About 686 people with moderate to severe facial acne used one of the treatments daily for 12 weeks. The goal was to see which gel worked better at reducing pimples and clearing the skin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bausch Site 101
Manhattan Beach, California, 90266, United States
-
Bausch Site 102
Tampa, Florida, 33607, United States
-
Bausch Site 103
Brighton, Massachusetts, 21350, United States
-
Bausch Site 104
West Palm Beach, Florida, 33401, United States
-
Bausch Site 105
Boynton Beach, Florida, 33437, United States
-
Bausch Site 106
San Diego, California, 92123, United States
-
Bausch Site 107
Gresham, Oregon, 97030, United States
-
Bausch Site 108
Las Vegas, Nevada, 89148, United States
-
Bausch Site 109
Dublin, Ohio, 43016, United States
-
Bausch Site 110
Fremont, California, 94538, United States
-
Bausch Site 111
Austin, Texas, 78759, United States
-
Bausch Site 112
San Diego, California, 92123, United States
-
Bausch Site 113
Saint-Jérôme, Quebec, J7Z 7E2, Canada
-
Bausch Site 114
Nashville, Tennessee, 37215, United States
-
Bausch Site 115
Peterborough, Ontario, K91 5K2, Canada
-
Bausch Site 116
Rockville, Maryland, 20850, United States
-
Bausch Site 117
Oklahoma City, Oklahoma, 73112, United States
-
Bausch Site 118
Rogers, Arkansas, 72758, United States
-
Bausch Site 119
New York, New York, 10022, United States
-
Bausch Site 120
New Brighton, Minnesota, 55112, United States
-
Bausch Site 121
Metairie, Louisiana, 70006, United States
-
Bausch Site 122
West Palm Beach, Florida, 33406, United States
-
Bausch Site 123
Pflugerville, Texas, 78660, United States
-
Bausch Site 124
Newnan, Georgia, 30263, United States
-
Bausch Site 125
Markham, Ontario, L3P 1X3, Canada
-
Bausch Site 126
Clearwater, Florida, 33761, United States
-
Bausch Site 127
Boise, Idaho, 83704, United States
-
Bausch Site 128
San Diego, California, 92123, United States
-
Bausch Site 129
Louisville, Kentucky, 40241, United States
-
Bausch Site 130
Waterloo, Ontario, N2J 1C4, Canada
-
Bausch Site 132
Houston, Texas, 77098, United States
-
Bausch Site 133
New York, New York, 10075, United States
-
Bausch Site 134
Bryant, Arkansas, 72022, United States
-
Bausch Site 135
North Miami Beach, Florida, 33162, United States
-
Bausch Site 136
Kortrijk, Belgium
-
Bausch Site 137
Spokane, Washington, 99202, United States
-
Bausch Site 138
Winnipeg, Manitoba, R3M 3Z4, Canada
-
Bausch Site 139
Mandeville, Louisiana, 70448, United States
-
Bausch Site 140
Maldegem, Belgium
-
Bausch Site 141
Oakville, Ontario, L6J 7W5, Canada
-
Bausch Site 142
High Point, North Carolina, 27262, United States
-
Bausch Site 143
Sanford, Florida, 32771, United States
Conditions
Explore the condition pages connected to this study.